ACS Catalysis
Page 4 of 5
(13) (a) Takahashi, M.; Oshima, K.; Matsubara, S. Chem. Lett.
AUTHOR INFORMATION
2005, 34, 192-193. (b) Maegawa, T.; Akashi, A.; Esaki, H.; Aoki, F.; Sajiki,
H.; Hirota, K. Synlett. 2005, 845-847. (c) Cioffi, E. A.; Bell, R. H.; Le, B.
Tetrahedron: Asymmetry 2005, 16, 471-475. (d) Taglang, C.; Martínez-
Prieto, L. M.; del Rosal, I.; Maron, L.; Poteau, R.; Philippot, K.; Chaudret,
B.; Perato, S.; Lone, A. S.; Puente, C.; Dugave, C.; Rousseau, B.; Pieters, G.
Angew. Chem. Int. Ed. 2015, 54, 10474-10477. (e) Jere, F. T.; Miller, D.
J.; Jackson, J. E. Org. Lett. 2003, 5, 527-530. (f) Hale, L. V. A.; Szymczak,
N. K. J. Am. Chem. Soc. 2016, 138, 13489-13492.
(14) Palmer, W. N.; Obligacion, J. V.; Pappas, I.; Chirik, P. J. J. Am.
Chem. Soc. 2016, 138, 766-769.
(15) Palmer, W. N.; Zarate, C.; Chirik, P. J. J. Am. Chem. Soc. 2017,
139, 2589-2592.
1
2
3
4
5
6
7
8
Corresponding Author
* pchirik@princeton.edu
Notes
The authors declare no competing financial interests.
ACKNOWLEDGMENT
An NSF GOALI (CHE-1564379) is acknowledged for financial sup-
port. WNP also acknowledges Eli Lilly for partial support through a
graduate fellowship.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(16) (a) Ishiyama, T.; Miyaura, N. Pure Appl. Chem. 2006, 78,
1369-1375. Ishiyama, T.; Miyaura, N. J. Organomet. Chem. 2003, 680, 3-
11. (c) Mkhalid, I. A. I.; Barnard, J. H.; Marder, T. B.; Murphy, J. M.; Hart-
wig, J. F. Chem. Rev. 2010, 110, 890-931. (d) Hartwig, J. F. Acc. Chem.
Res. 2012, 45, 864-873.
(17) (a) Obligacion, J. V.; Semproni, S.; Chirik, P. J. J. Am. Chem.
Soc. 2014, 136, 4133-4136. (b) Schaefer, B. A.; Margulieux, G. W.; Small,
B. L.; Chirik, P. J. Organometallics 2015, 34, 1307-1320. (c) Obligacion, J.
V.; Semproni, S. P.; Pappas, I.; Chirik, P. J. J. Am. Chem. Soc. 2016, 138,
10645-10653. (d) Léonard, N. G.; Bezdek, M. J.; Chirik, P. J. Organometal-
lics 2017, 36, 142-150. (e) Obligacion, J. V.; Bezdek, M. J.; Chirik, P. J. J.
Am. Chem. Soc. 2017, 139, 2825-2823.
(18) Palmer, W. N.; Diao, T.; Pappas, I.; Chirik, P. J. ACS Catal.
2015, 5, 622-626.
(19) The electron-deficient nature of the substrate may favor arene
reduction compared to toluene under identical reaction conditions (20%,
see SI, Table S1) and may also account for a lack of HIE at 50 °C due to less
reversible substrate coordination to the catalyst.
REFERENCES
(1)
(a) Burwell Jr., R. L. Acc. Chem. Res. 1969, 2, 289-296. (b)
Labinger, J. A.; Bercaw, J. E. Nature 2002, 417, 507-514. (c) Jones, W. D.
Acc. Chem. Res. 2003, 36, 140-146. (d) Lersch, M.; Tilset, M. Chem. Rev.
2005, 105, 2471-2526.
(2)
(a) Voges, R.; Heys, J. R.; Moenius, T. Preparation of Com-
pounds Labeled with Tritium and Carbon-14; John Wiley and Sons, Inc.:
New York, 2009. (b) Isin, E. M.; Elmore, C. S.; Nilsson, G. N.; Thompson,
R. A.; Weidolf, L. Chem. Res. Toxicol. 2012, 25, 532-542. (c) Lockley, W.
J. S.; McEwen, A.; Cooke, R. J. Labelled Comp. Radiopharm. 2012, 55,
235-257. (d) Gant, T. G. J. Med. Chem. 2014, 57, 3595-3611.
(3)
(a) Belleau, B.; Burba, J.; Pindell, M.; Reiffenstein, J. Science
1961, 133, 102-104. (b) Meanwell, N. A. J. Med. Chem. 2011, 54, 2529-
2591. (c) Katsnelson, A. Nature Med. 2013, 19, 656.
(4)
1075. (b) Halford, B. Chem. Eng. News 2016, 94, 32-36.
(5) (a) Junk, T.; Catallo, W. J. Chem. Soc. Rev. 1997, 26, 401-406.
(a) Timmins, G. S. Expert Opin. Ther. Pat. 2014, 24, 1067-
(20) Shimada, S.; Batsanov, A. S.; Howard, J. A. K.; Marder, T. B.
Angew. Chem. Int. Ed. 2001, 40, 2168-2171.
(b) Atzrodt, J.; Derdau, V.; Fey, T.; Zimmermann, J. Angew. Chem. Int.
Ed. 2007, 46, 7744-7765. (c) Lockley, W. J. S.; Heys, J. R. J. Labelled
Comp. Radiopharm 2010, 53, 635-644.
(21)
(a) Pereira, S.; Srebnik, M. Tetrahedron Lett. 1995, 36, 1805-
1808. (b) Joannou, M. V.; Moyer, B. S.; Meek, S. J. J. Am. Chem. Soc.
2015, 137, 6176-6179. (c) Joannou, M. V.; Moyer, B. S.; Goldfogel, M. J.;
Meek, S. J. Angew. Chem. Int. Ed. 2015, 54, 14141-14145. (d) Endo, K.;
Ohkubo, T.; Hirokami, M.; Shibata, T. J. Am. Chem. Soc. 2010, 132,
11033-11035. (e) Sun, C.; Potter, B.; Morken, J. P. J. Am. Chem. Soc.
2014, 136, 6534-6537.
(22) (a) Rathke, M. W.; Kow, R. J. Am. Chem. Soc. 1972, 94, 6854-
6856. (b) Matteson, D. S.; Moody, R. J. J. Am. Chem. Soc. 1977, 29, 3196-
3197. (c) Matteson, D. S.; Moody, R. J. Organometallics 1982, 1, 20-28.
(23) The rate constant of cyclopropane ring-opening of the corre-
sponding cyclopropylbenzyl radical was previously determined to be 2.7 x
105 s-1 at 22 °C in hexane solution: Masnovi, J.; Samsel, E. G.; Bullock, R. M.
J. Chem. Soc., Chem. Commun. 1989, 1044-1045.
(6)
(a) Jones, W. D.; Feher, F. J. Acc. Chem. Res. 1989, 22, 91-100.
(b) Xue, X.-S.; Ji, P.; Zhou, B.; Cheng, J.-P. Chem. Rev. 2017, 117, 8622-
8648.
(7)
(a) Hesk, D.; Das, P. R.; Evans, B. J. Labelled Comp. Radio-
pharm. 1995, 36, 497-502. (b) Herbert, J. M. J. Labelled Comp. Radio-
pharm. 2010, 53, 658-661. (c) Nilsson, G. N.; Kerr, W. J. Labelled Comp.
Radiopharm. 2010, 53, 662-667. (d) Brown, J. A.; Cochrane, A. R.; Irvine,
S.; Kerr, W. J.; Mondal, B.; Parkinson, J. A.; Paterson, L. C.; Reid, M.; Tut-
tle, T.; Andersson, S.; Nilsson, G. N. Adv. Synth. Catal. 2014, 356, 3551-
3562.
(8) Yu, R. P.; Hesk, D.; Rivera, N.; Pelczer, I.; Chirik, P. J. Nature
2016, 529, 195-199.
(9) Atkinson, J. G.; Luke, M. O.; Stuart, R. S. Can. J. Chem. 1967,
45, 1511-1518.
(10) Heys, J. R. J. Labelled Comp. Radiopharm. 2010, 53, 716-721.
(11) Tsukinoki, T.; Ishimoto, K.; Mukumoto, M.; Suzuki, M.; Kawa-
ji, T.; Nagano, Y.; Tsuzuki, H.; Mataka, S.; Tashiro, M. J. Chem. Res. Syn-
op. 1996, 1, 66-67.
(12) Azran, J.; Shimoni, M.; Buchman, O. J. Catal. 1994, 148, 648-
653.
(24) Percent “es”, or enantiospecificity, indicates the percentage of
the reaction that proceeds with enantioretention and is defined as: % es =
(% ee of product) / (% ee of starting material) * 100.
ACS Paragon Plus Environment